The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth pediatric heart transplantation report — 2021; focus on recipient characteristics
Section snippets
Data collection, conventions, and statistical methods
The 2021 International Thoracic Organ Transplant Registry report, as in past years, was developed using data submitted to the Registry from national and multinational transplant collectives as well as individual transplant centers. Between 2010 and 2018, 210 centers performing heart transplants in pediatric recipients contributed data to the Registry.1
This report presents an overview of characteristics of pediatric recipients of deceased donor heart alone transplants and their association with
Recipient characteristics
A comparison of baseline characteristics between pediatric recipients during the years 1992 to 2000, 2001 to 2009, and 2010 to 2018 is shown in Table 1 and eSlides H(p) 4 to 7. In each successive era, the number of pediatric heart transplant recipients increased in Europe, North America, and Other regions as heart transplantation became more widely available (eSlide H[p] 4-7). The proportion of pediatric heart transplants performed in North American centers has remained stable at ∼68%, while
One-year survival
Overall, 1-year post-transplant survival improved from 87% during 2000 to 2005 to 92% during 2012 to 2017 (eSlide H[p] 14). We examined the associations between recipient characteristics and 1-year survival during 2000 to 2017, focusing on how 1-year survival has changed in recipients stratified by specific characteristics. In all regions, overall 1-year survival among pediatric recipients was highest during 2012 to 2017 (Figure 2 and eSlide H[p] 15), however, the improvement did not reach
Conclusion
In this focused report, we present changes in baseline characteristics over the past 3 decades in pediatric heart transplant recipients. The median pediatric recipient age has increased over time, primarily because more transplants are being performed in children >1-year-old. Despite the widespread use of durable ventricular assist devices in the current era, over two-thirds of pediatric recipients receive a transplant while hospitalized, a majority while supported on inotropes, and 1 in 6
Disclosure statement
The authors have no conflicts of interest to disclose. Daniel C. Chambers received travel support from Astellas Pharma, Inc, and serves as a consultant and speaker for Roche Ltd; Kiran K. Khush serves as a consultant and speaker for CareDx, Inc; Josef Stehlik serves as a consultant for Medtronic, received research support from Natera and received funding from ISHLT; Michael Perch receives research funding from Roche, travel support from Boeringer-Ingelheim, and is a speaker for Mallinckrodt,
Acknowledgments
The authors wish to thank Ms. Lyna Cherikh, United Network of Organ Sharing Research Summer Intern, for her assistance with preparing the figures/table for the manuscript and reviewing the manuscript.
References (8)
- et al.
The international thoracic organ transplant registry of the international society for heart and lung transplantation: twenty-second pediatric heart transplantation report - 2019; focus theme: donor and recipient size match
J Heart Lung Transplant
(2019) - et al.
Fourth annual pediatric interagency registry for mechanical circulatory support (pedimacs) report
Ann Thorac Surg
(2020) - et al.
The international thoracic organ transplant registry of the international society for heart and lung transplantation: 23rd pediatric heart transplantation report-2020; focus on deceased donor characteristics
J Heart Lung Transplant
(2020) - et al.
Registry of the international society for heart and lung transplantation: twenty-sixth official adult heart transplant report-2009
J Heart Lung Transplant
(2009)